|
|
|
|
LEADER |
00000cam a2200000 a 4500 |
001 |
ocn681543069 |
003 |
OCoLC |
005 |
20241006213017.0 |
006 |
m o d |
007 |
cr cnu---unuuu |
008 |
101116s2006 ii a ob 000 0 eng d |
040 |
|
|
|a N$T
|b eng
|e pn
|c N$T
|d OCLCQ
|d E7B
|d OCLCQ
|d OCLCF
|d NLGGC
|d YDXCP
|d MERUC
|d EBLCP
|d AU@
|d OCLCQ
|d AZK
|d LOA
|d COCUF
|d MOR
|d PIFAG
|d ZCU
|d OCLCQ
|d U3W
|d STF
|d WRM
|d ICG
|d NRAMU
|d VT2
|d OCLCQ
|d WYU
|d DKC
|d OCLCQ
|d UKCRE
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCL
|d OCLCQ
|
019 |
|
|
|a 680627109
|a 700692367
|a 764545097
|a 842269773
|a 904228028
|a 961496235
|a 962566267
|a 966261412
|a 988411024
|a 992100476
|a 1037939600
|a 1038643099
|a 1045523732
|a 1057998552
|a 1081205253
|a 1153563278
|
020 |
|
|
|a 9781441661395
|q (electronic bk.)
|
020 |
|
|
|a 1441661395
|q (electronic bk.)
|
020 |
|
|
|a 9789350435298
|
020 |
|
|
|a 9350435292
|
020 |
|
|
|a 8183186203
|q (electronic bk.)
|
020 |
|
|
|a 9788183186209
|q (electronic bk.)
|
020 |
|
|
|z 9788183186209
|
035 |
|
|
|a (OCoLC)681543069
|z (OCoLC)680627109
|z (OCoLC)700692367
|z (OCoLC)764545097
|z (OCoLC)842269773
|z (OCoLC)904228028
|z (OCoLC)961496235
|z (OCoLC)962566267
|z (OCoLC)966261412
|z (OCoLC)988411024
|z (OCoLC)992100476
|z (OCoLC)1037939600
|z (OCoLC)1038643099
|z (OCoLC)1045523732
|z (OCoLC)1057998552
|z (OCoLC)1081205253
|z (OCoLC)1153563278
|
050 |
|
4 |
|a RM301.4
|b .J64 2006eb
|
072 |
|
7 |
|a MED
|x 071000
|2 bisacsh
|
049 |
|
|
|a HCDD
|
100 |
1 |
|
|a Jogdand, S. N.
|
245 |
1 |
0 |
|a Biopharmaceuticals /
|c S.N. Jogdand.
|
250 |
|
|
|a 1st ed.
|
260 |
|
|
|a Mumbai :
|b Himalaya Pub. House,
|c 2006.
|
300 |
|
|
|a 1 online resource (277 pages) :
|b illustrations
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
347 |
|
|
|a data file
|2 rda
|
504 |
|
|
|a Includes bibliographical references.
|
588 |
0 |
|
|a Print version record.
|
505 |
0 |
|
|a COVER; CONTENTS; INTRODUCTION; MARKET FOR BIOPHARMACEUTICALS; BIOPHARMACEUTICAL INDUSTRY; BIOPHARMACEUTICAL SECTOR IN INDIA; DRUG DISCOVERY AND DRUG DESIGNING; PHARMACOKINETICS; CLINICAL TRIALS; REGULATORY; THERAPEUTIC PROTEINS; BLOOD PRODUCTS; MONOCLONAL ANTIBODIES; HORMONE THERAPY; VACCINE PRODUCTION-NEW DEVELOPMENTS; TRANSGENIC PRODUCTION OF BIOPHARMACEUTICALS; HUMAN GENE THERAPY; ANTISENSE TECHNOLOGY (DNA MEDICINES).
|
520 |
|
|
|a Biopharmaceuticals are complex macromolecules created through the genetic manipulation of living organisms using gene cloning, recombinant DNA(gene splicing), or fusion technologies. Although small molecule drugs remain the standard treatment for disease, new strategies based on the engineering of proteins, genes and cell as therapeutic agents will revolutionize medicine in the coming decades. More than 20 percent of new medicines launched in 2003 were produced using biotechnology, nearly 80 percent of those under development either use use of biotechnology or are derived from it. The biopharm.
|
650 |
|
0 |
|a Biopharmaceutics.
|
650 |
|
7 |
|a MEDICAL
|x Pharmacology.
|2 bisacsh
|
650 |
|
7 |
|a Biopharmaceutics
|2 fast
|
776 |
0 |
8 |
|i Print version:
|a Jogdand, S.N.
|t Biopharmaceuticals.
|b 1st ed.
|d Mumbai : Himalaya Publishing House, 2006
|z 9788183186209
|
856 |
4 |
0 |
|u https://ebookcentral.proquest.com/lib/holycrosscollege-ebooks/detail.action?docID=588365
|y Click for online access
|
903 |
|
|
|a EBC-AC
|
994 |
|
|
|a 92
|b HCD
|